14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Sep 07, 2022 Buy 3 000 Zukiwski Alexander A Employee Stock Option (Right to Buy)
Sep 06, 2022 Buy 33 300 Huang James Common Stock
Aug 31, 2022 Buy 400 Huang James Common Stock
Aug 24, 2022 Buy 39 527 Huang James Common Stock
Aug 19, 2022 Buy 40 000 Huang James Common Stock
Jun 15, 2022 Buy 50 000 He Wei-wu Common Stock
Jun 13, 2022 Buy 2 096 He Wei-wu Common Stock
Jun 13, 2022 Buy 36 058 He Wei-wu Common Stock
May 25, 2022 Buy 380 645 Zhou Quan Stock Option (Right to Buy)
May 25, 2022 Buy 380 645 Zhou Quan Stock Option (Right to Buy)
May 25, 2022 Buy 397 419 Huang James Stock Option (Right to Buy)
May 25, 2022 Buy 388 387 Wu Yue Alexander Stock Option (Right to Buy)
May 25, 2022 Buy 388 387 Wu Yue Alexander Stock Option (Right to Buy)
May 25, 2022 Buy 388 387 Salisbury Franklin Cary Jr Stock Option (Right to Buy)
May 25, 2022 Buy 388 387 Salisbury Franklin Cary Jr Stock Option (Right to Buy)
May 25, 2022 Buy 345 806 Shrotriya Rajesh C Md Stock Option (Right to Buy)
Dec 02, 2021 Sell 500 000 Zukiwski Alexander A Employee Stock Option (Right to Buy)
Nov 18, 2021 Buy 200 000 He Wei-wu Common Stock
Nov 17, 2021 Buy 200 000 He Wei-wu Common Stock
Aug 19, 2021 Buy 180 000 He Wei-wu Common Stock
Aug 18, 2021 Buy 300 000 He Wei-wu Common Stock
Jul 24, 2021 Sell 800 000 Zhang Larry Employee Stock Option (Right to Buy)
Jun 15, 2021 Buy 108 257 Zhou Quan Stock Option (Right to Buy)
Jun 15, 2021 Buy 110 459 Wu Yue Alexander Stock Option (Right to Buy)
Jun 15, 2021 Buy 98 Shrotriya Rajesh C Md Stock Option (Right to Buy)
Jun 15, 2021 Buy 110 459 Salisbury Franklin Cary Jr Stock Option (Right to Buy)
Jun 15, 2021 Buy 113 028 Huang James Stock Option (Right to Buy)
Jun 15, 2021 Buy 4 000 000 He Wei-wu Stock Options (Right to Buy)
Mar 26, 2021 Buy 3 000 000 He Wei-wu Common Stock
Dec 22, 2020 Sell 380 000 He Wei-wu Common Stock
Dec 17, 2020 Buy 2 279 Xu Weihao Common Stock
Dec 17, 2020 Buy 1 721 Xu Weihao Common Stock
Dec 16, 2020 Buy 800 000 Xu Weihao Employee Stock Option (Right to Buy)
Dec 16, 2020 Buy 2 000 Xu Weihao Common Stock
Dec 16, 2020 Buy 0 Xu Weihao Common Stock
Nov 23, 2020 Buy 100 000 He Wei-wu Common Stock
Nov 20, 2020 Buy 127 471 He Wei-wu Common Stock
Jul 22, 2020 Buy 20 153 Zhang Larry Common Stock
Jul 22, 2020 Buy 1 200 000 He Wei-wu Common Stock
Jul 22, 2020 Buy 2 952 426 He Wei-wu Common Stock
Jun 16, 2020 Buy 67 429 Zhou Quan Stock Option (Right to Buy)
Jun 16, 2020 Buy 70 400 Huang James Stock Option (Right to Buy)
Jun 16, 2020 Buy 68 800 Wu Yue Alexander Stock Option (Right to Buy)
Jun 16, 2020 Buy 68 800 Wu Yue Alexander Stock Option (Right to Buy)
Jun 16, 2020 Buy 68 800 Salisbury Franklin Cary Jr Stock Option (Right to Buy)
Jun 16, 2020 Buy 61 257 Shrotriya Rajesh C Md Stock Option (Right to Buy)
May 20, 2020 Buy 56 464 He Wei-wu Common Stock
May 19, 2020 Buy 29 801 He Wei-wu Common Stock
May 18, 2020 Buy 338 932 He Wei-wu Common Stock
May 15, 2020 Buy 100 000 He Wei-wu Common Stock
Mar 27, 2020 Buy 6 880 He Wei-wu Common Stock
Mar 26, 2020 Buy 328 095 He Wei-wu Common Stock
Mar 25, 2020 Buy 196 398 He Wei-wu Common Stock
Mar 19, 2020 Buy 234 488 He Wei-wu Common Stock
Mar 18, 2020 Buy 501 322 He Wei-wu Common Stock
Mar 17, 2020 Buy 264 192 He Wei-wu Common Stock
Dec 30, 2019 Buy 493 827 Wealth Strategy Holding Ltd Common Stock
Dec 30, 2019 Sell 493 827 Wealth Strategy Holding Ltd Warrant
Dec 16, 2019 Buy 374 321 He Wei-wu Common Stock
Dec 16, 2019 Sell 374 321 He Wei-wu Warrant
Dec 15, 2019 Sell 200 000 Zukiwski Alexander A Employee Stock Option (Right to Buy)
Sep 20, 2019 Sell 200 000 Zhang Larry Employee Stock Option (Right to Buy)
Aug 16, 2019 Buy 20 000 He Wei-wu Common Stock
Aug 14, 2019 Buy 160 000 He Wei-wu Common Stock
Aug 14, 2019 Buy 160 000 He Wei-wu Common Stock
Jun 20, 2019 Buy 59 231 Huang James Stock Option (Right to Buy)
Jun 20, 2019 Buy 57 885 Wu Yue Alexander Stock Option (Right to Buy)
Jun 20, 2019 Buy 57 885 Salisbury Franklin Cary Jr Stock Option (Right to Buy)
Jun 20, 2019 Buy 51 538 Ren Ken Keyong Stock Option (Right to Buy)
Jun 20, 2019 Buy 51 538 Shrotriya Rajesh C Md Stock Option (Right to Buy)
Jun 20, 2019 Buy 4 000 000 He Wei-wu Stock Option (Right to Buy)
Jun 20, 2019 Buy 56 731 Zhou Quan Stock Option (Right to Buy)
Apr 02, 2019 Sell 1 500 000 Spectrum Pharmaceuticals Inc Common Stock
Mar 23, 2019 Buy 167 910 Li Dapeng Warrant (right to buy)
Mar 23, 2019 Buy 559 701 Wealth Strategy Holding Ltd Warrant
Jan 29, 2019 Buy 75 000 Ren Ken Keyong Stock Options (Right to Buy)
Jan 29, 2019 Buy 75 000 Hu Cynthia W. Stock Options (Right to Buy)
Jan 14, 2019 Buy 15 000 Hu Cynthia W. Common Stock
Jan 14, 2019 Sell 3 100 Hu Cynthia W. Common Stock
Jan 14, 2019 Sell 15 000 Hu Cynthia W. Employee Stock Option (Right to Buy)
Dec 19, 2018 Sell 200 000 He Wei-wu Common Stock
Dec 03, 2018 Buy 720 000 Ren Ken Keyong Stock Options (Right to Buy)
Nov 13, 2018 Buy 1 699 753 Sparkle Byte Ltd Common Stock
Nov 13, 2018 Sell 750 771 Sparkle Byte Ltd Warrant
Oct 01, 2018 Buy 1 000 000 Zhang Larry Stock Options (Right to Buy)
Sep 28, 2018 Buy 400 000 Chi George Stock Options (Right to Buy)
Sep 28, 2018 Buy 0 Chi George
Sep 24, 2018 Buy 0 Wealth Strategy Holding Ltd Common Stock
Sep 17, 2018 Buy 370 370 Wealth Strategy Holding Ltd Warrant
Sep 11, 2018 Buy 0 Li Dapeng Common Stock
Jul 12, 2018 Buy 35 000 Capitelli Sara B Common Stock
Jul 12, 2018 Sell 8 400 Capitelli Sara B Common Stock
Apr 17, 2018 Buy 616 375 Li Dapeng Warrant (right to buy)
Apr 17, 2018 Buy 616 375 Li Dapeng Warrant (right to buy)
Apr 17, 2018 Buy 666 666 Wealth Strategy Holding Ltd Warrant
Oct 13, 2017 Buy 0 Li Dapeng Common Stock
Oct 13, 2017 Buy 0 Li Dapeng Common Stock
Jan 23, 2017 Buy 493 827 Wealth Strategy Holding Ltd Warrant
Jan 02, 2017 Buy 246 913 Li Dapeng Warrant (right to buy)
Jan 02, 2017 Buy 246 913 Li Dapeng Warrant (right to buy)
INSIDER POWER
13.498
Last 100 transactions
Buy: 32 800 612 | Sell: 5 425 419 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 13.498.

In total, the insiders bought 32 800 612 349 and sold 5 425 419 CASI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT